{"log_id": 4000890643595493274, "direction": 0, "words_result_num": 40, "words_result": [{"probability": {"variance": 7e-06, "average": 0.997334, "min": 0.994706}, "location": {"width": 46, "top": 170, "height": 25, "left": 270}, "words": "头痛"}, {"probability": {"variance": 0, "average": 0.999942, "min": 0.99985}, "location": {"width": 84, "top": 202, "height": 25, "left": 271}, "words": "感觉异常"}, {"probability": {"variance": 7e-06, "average": 0.989555, "min": 0.986974}, "location": {"width": 44, "top": 235, "height": 23, "left": 270}, "words": "胸痛"}, {"probability": {"variance": 8e-06, "average": 0.996549, "min": 0.993444}, "location": {"width": 85, "top": 265, "height": 24, "left": 270}, "words": "尿路感染"}, {"probability": {"variance": 0.044229, "average": 0.786875, "min": 0.500644}, "location": {"width": 44, "top": 297, "height": 23, "left": 269}, "words": "牙才病"}, {"probability": {"variance": 0, "average": 0.999991, "min": 0.999984}, "location": {"width": 43, "top": 329, "height": 23, "left": 270}, "words": "过敏"}, {"probability": {"variance": 0, "average": 0.768345, "min": 0.768345}, "location": {"width": 22, "top": 328, "height": 21, "left": 816}, "words": "1"}, {"probability": {"variance": 0.031168, "average": 0.910993, "min": 0.389343}, "location": {"width": 504, "top": 368, "height": 24, "left": 342}, "words": "空白对照研究中瑞格列奈组的发生率2%且空白对照折"}, {"probability": {"variance": 0.000482, "average": 0.990724, "min": 0.936965}, "location": {"width": 144, "top": 416, "height": 23, "left": 113}, "words": "心血管不良反应"}, {"probability": {"variance": 0.001531, "average": 0.985772, "min": 0.752932}, "location": {"width": 914, "top": 460, "height": 27, "left": 155}, "words": "在为期一年的瑞格列奈和酰脲类药物的对照试验中,两者心绞痛的发生率相当(1.8%),胸的发生"}, {"probability": {"variance": 0.016817, "average": 0.933946, "min": 0.477154}, "location": {"width": 957, "top": 507, "height": 24, "left": 111}, "words": "率,瑞格列奈组为1.8%,磺酰脲纽为1.0%。选择性心血管不良反应高血乐、心电图异常、心肌梗死、心"}, {"probability": {"variance": 0.017603, "average": 0.930279, "min": 0.455994}, "location": {"width": 654, "top": 554, "height": 25, "left": 112}, "words": "律不齐和心悸的发生率,瑞格列奈组和对照药物组没有差异,均≤1.0%"}, {"probability": {"variance": 0.001914, "average": 0.987318, "min": 0.723729}, "location": {"width": 848, "top": 599, "height": 26, "left": 153}, "words": "在对照比较的临床试验中,包括缺血在内的严重心血管不良反应的总发生率方面,端格列奈"}, {"probability": {"variance": 0.010516, "average": 0.94461, "min": 0.538529}, "location": {"width": 958, "top": 646, "height": 25, "left": 111}, "words": "要高于磺酰脲组(3%)在一项为期1年的对照试验中,与其他口服降糖药观察到的儿率相比,瑞格列奈治"}, {"probability": {"variance": 0.04344, "average": 0.886132, "min": 0.409972}, "location": {"width": 186, "top": 695, "height": 22, "left": 111}, "words": "疗没有较高的死广"}, {"probability": {"variance": 0.01089, "average": 0.970238, "min": 0.566585}, "location": {"width": 337, "top": 739, "height": 25, "left": 424}, "words": "表2瑞格列奈和磺酰尿类对照试验中"}, {"probability": {"variance": 0.000402, "average": 0.99266, "min": 0.889081}, "location": {"width": 651, "top": 786, "height": 26, "left": 264}, "words": "严重心血管不良反应发生几率(占发生不良反应患者总数的比例)概况"}, {"probability": {"variance": 0.035194, "average": 0.881756, "min": 0.556899}, "location": {"width": 84, "top": 837, "height": 24, "left": 461}, "words": "瑞格列奈"}, {"probability": {"variance": 0.002273, "average": 0.950947, "min": 0.869765}, "location": {"width": 85, "top": 837, "height": 25, "left": 741}, "words": "磺酰尿类"}, {"probability": {"variance": 0.005653, "average": 0.958811, "min": 0.791175}, "location": {"width": 125, "top": 886, "height": 25, "left": 179}, "words": "总受试者人数"}, {"probability": {"variance": 3e-06, "average": 0.99485, "min": 0.992819}, "location": {"width": 30, "top": 888, "height": 19, "left": 470}, "words": "228"}, {"probability": {"variance": 0.005793, "average": 0.915215, "min": 0.839106}, "location": {"width": 19, "top": 889, "height": 18, "left": 748}, "words": "98"}, {"probability": {"variance": 0.000483, "average": 0.99047, "min": 0.929295}, "location": {"width": 185, "top": 931, "height": 25, "left": 182}, "words": "严重心血管不良反应"}, {"probability": {"variance": 5.1e-05, "average": 0.994625, "min": 0.98242}, "location": {"width": 82, "top": 977, "height": 25, "left": 179}, "words": "心脏缺血"}, {"probability": {"variance": 0.001187, "average": 0.962971, "min": 0.928518}, "location": {"width": 25, "top": 979, "height": 23, "left": 460}, "words": "2%"}, {"probability": {"variance": 0.0631, "average": 0.574852, "min": 0.394164}, "location": {"width": 84, "top": 977, "height": 34, "left": 684}, "words": "2"}, {"probability": {"variance": 0.007952, "average": 0.955166, "min": 0.740822}, "location": {"width": 146, "top": 1025, "height": 26, "left": 179}, "words": "死于心血管事件"}, {"probability": {"variance": 1e-06, "average": 0.971746, "min": 0.970679}, "location": {"width": 18, "top": 1028, "height": 20, "left": 483}, "words": "5%"}, {"probability": {"variance": 0.022064, "average": 0.93567, "min": 0.518921}, "location": {"width": 191, "top": 1077, "height": 24, "left": 250}, "words": "格列本脲和格列吡嗪"}, {"probability": {"variance": 0.009576, "average": 0.924656, "min": 0.760158}, "location": {"width": 208, "top": 1058, "height": 46, "left": 613}, "words": "限公司人"}, {"probability": {"variance": 0.005321, "average": 0.97058, "min": 0.676614}, "location": {"width": 554, "top": 1121, "height": 28, "left": 136}, "words": "7项对照临床试验中,包括瑞格列奈和低精蛋白锌胰岛素价用"}, {"probability": {"variance": 0.017069, "average": 0.927221, "min": 0.580193}, "location": {"width": 272, "top": 1124, "height": 24, "left": 794}, "words": "单用胰岛泰制剂(n=388)以及"}, {"probability": {"variance": 0.004525, "average": 0.966506, "min": 0.691901}, "location": {"width": 714, "top": 1169, "height": 27, "left": 105}, "words": "其他合用方案(磺酰脲+低精蛋白锌胰岛素,或者瑞格列奈十二甲双胍)(n=120"}, {"probability": {"variance": 0.000895, "average": 0.990307, "min": 0.808475}, "location": {"width": 919, "top": 1216, "height": 27, "left": 148}, "words": "在两项研究中,瑞格列奈十低精蛋白锌胰岛素治疗的患者中共有6例出现了心肌缺血这一严重的不良反"}, {"probability": {"variance": 0.002312, "average": 0.989146, "min": 0.722063}, "location": {"width": 667, "top": 1264, "height": 26, "left": 105}, "words": "应,在另一项研究中,单用胰岛索制剂的患者中则有1例出现该不良反应"}, {"probability": {"variance": 0, "average": 0.999191, "min": 0.998314}, "location": {"width": 127, "top": 1313, "height": 25, "left": 104}, "words": "其他不良反应"}, {"probability": {"variance": 0.003952, "average": 0.981377, "min": 0.612574}, "location": {"width": 906, "top": 1358, "height": 27, "left": 148}, "words": "临床试验中观察到的少见临床和实验室不良反应包括过敏反应、肝酶升高、血小板减少和白细胞减少"}, {"probability": {"variance": 0.004679, "average": 0.977547, "min": 0.627929}, "location": {"width": 957, "top": 1403, "height": 31, "left": 107}, "words": "非常罕见的不良反应有眼睛异常(已知血糖水平的改变可导致暂时性的视觉异常,尤其是在开始使用降糖"}, {"probability": {"variance": 0.000469, "average": 0.993537, "min": 0.882572}, "location": {"width": 604, "top": 1453, "height": 26, "left": 106}, "words": "药物进行治疗时,这些改变通常是一过性的)或免疫反应如脉管炎"}, {"probability": {"variance": 0.001198, "average": 0.987772, "min": 0.833227}, "location": {"width": 910, "top": 1500, "height": 27, "left": 145}, "words": "虽然尚未确定与瑞格列奈之间的因果关系,但是上市后报道的罕见不良反应如下:脱发、溶血性贫自"}], "language": 3}